Lead: King’s College London
Higher education partners: University College London, Imperial College London, Queen Mary University of London, University of Bristol, The University of Manchester, Newcastle University, University of Cardiff, University of Birmingham, University of Edinburgh, University of Glasgow, Queen’s University Belfast
CCF award: £1.32 million
About the project
Advanced therapies include a variety of novel gene-based and cell-based techniques, which can be used to treat a wide range of serious conditions.
Funded through a Research England Connecting Capabilities Fund award, London Advanced Therapies (LAT) was established in 2018. Since then, the programme has delivered an accessible and comprehensive package of activities that encourage:
- universities to accelerate knowledge transfer between them
- industry to benefit from London’s expertise in this field, which is a key growth area for life sciences in the UK and worldwide.
Among the forms of knowledge exchange that LAT supports, for example, is the mapping of expertise. This enables any life science company working in advanced therapies – anywhere in the world – to be put in touch with relevant experts within hours.
The project’s impacts
The additional funding will support the establishment of a nation-wide collaboration, UK Advanced Therapies (UKAT). This will create a bridge between a successful London-focused endeavour and a UK wide, comprehensive network. Working together across the regions and nations will:
- lead to more inward investment
- make the project’s capabilities readily accessible
- translate them into a competitive advantage to industry.
This will further enhance the UK’s position as global leader in the field.
Find out more
Visit the Advance Therapies Network website.